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Introduction: The podocyturia has 
been detected in glomerular diseases, 
such as lupus nephritis (LN), in which 
proteinuria is an important manifes-
tation, and its occurrence seems to be 
limited to the active phase of the dis-
ease. Objective: To evaluate podocy-
turia in LN patients, and the possible 
association with clinical disease ac-
tivity. Methods: We evaluated 56 pa-
tients with LN, that were classified 
in three groups according to the de-
gree of clinical activity: Group B, no 
activity (n = 17), Group C with mild 
(n = 29) and Group D, moderate to 
severe activity (n = 10). The control 
group was composed by 29 healthy 
subjects (Group A). The podocytu-
ria was studied by indirect immuno-
fluorescence using primary antibodies 
to podocyte: anti-podocin, nephrin 
and synaptopodin, and a second-
ary antibody conjugated with FITC. 
We also evaluated serum creatinine 
levels, urinary protein/creatinine (P/C) 
ratio, hematuria and leucocituria. 
Results: The podocyturia with anti-
podocin and anti-sinaptopodin cor-
related statistically with the P/C ratio 
(p = 0.001 and p = 0.013, respectively). 
The podocyturia with anti-podocin, 
as well as the P/C ratio showed sig-
nificant correlation (p < 0.001) with 
the degree of lupus disease activ-
ity, unlike the other two antibodies, 
anti-nephrin and anti-synaptopodin. 
Conclusion: Our findings show that 
podocyturia with anti-podocin could 
be useful in monitoring disease activity 
in LN patients.
AbstrAct
Keywords: glomerulonephritis, lupus ne-
phritis, podocytes, proteinuria.
IntroductIon
Podocytes or visceral epithelial cells are 
highly specialized cells which line the 
urinary surface of the glomerular capillary 
tuft and, together with endothelial cells 
and the basement membrane, form the 
glomerular filtration barrier and provide 
for its selective permeability. After 
injury, podocytes may detach from the 
glomerular basement membrane and be 
excreted in urine; in this situation, they 
may still be viable, or have undergone 
apoptosis or necrosis.1
Animal experiments and clinical 
studies with glomerulopathy patients 
have shown that injury to podocytes 
plays a key role in the development of 
proteinuria.2 The presence of podocytes 
in urine has been described in many 
glomerular diseases, such as IgA 
nephropathy, diabetic nephropathy, 
membranous nephropathy, and lupus 
nephritis (LN),3,4 among others, reflecting 
the occurrence of glomerular injury.
One of the assays used to assess 
podocyturia is indirect immunofluores-
cence with specific antibodies directed 
against podocyte antigens in urinary sedi-
ments. The quantification of podocytes in 
the different stages of glomerular disease 
may contribute to the understanding of 
the condition’s pathogenesis. Podocyturia 
tests may also be a practical means of 
monitoring patients with glomerulopathy. 
The noninvasive nature of the tests 
and the real-time data they provides on 
podocyte injury in the glomerulus yield 
potential applications in the assessment of 
glomerular disease clinical activity.
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LN is one of the most severe clinical manifes-
tations of systemic lupus erythematosus (SLE). 
Studies have shown that podocyte injury occurs in 
the early stages of glomerular damage in LN,5 and 
that quantification of podocyturia could be used as 
a marker for active disease.6,7
This study aimed to analyze the use of immuno-
fluorescence assays for podocyturia in patients with 
LN. This simple low cost technique requires com-
mercially available podocyte-specific antibodies.
Methods
the series
The study included patients followed up in the 
Glomerulopathy Clinic of the Federal University 
of São Paulo (UNIFESP) diagnosed with LN and 
SLE as per the criteria of the American College of 
Rheumatology.8
Patients with LN were divided into three 
groups according to the degree of disease activity: 
17 (20.0%) had no active disease (Group B, 
14 females and three males, mean age 41.4 years); 
29 (34.1%) had mild disease (Group C, 22 females 
and seven males, mean age of 37.8 years); and 10 
(11.8%) had moderate to severe disease (Group D, 
all females, mean age of 29.6 years). Twenty-nine 
(34.1%) healthy individuals without urinary 
disorders were enrolled in the the control group 
(Group A, 21 females and eight males, mean age of 
40.7 years). They were selected based on negative 
urine test strip results.
Clinical and workup criteria were applied by an 
experienced physician in the area of lupus nephritis 
monitoring to grade disease activity (no active disease, 
mild disease, moderate to severe disease). Clinical 
criteria included signs and symptoms manifested in 
the patients and treatment with immunosuppressants; 
workup criteria included the results of tests routinely 
used to monitor patients with SLE in our service as 
described by Solorzano et al.9
POdOcyturia testing
Samples of midstream urine were collected in 
sterile vials and kept under refrigeration until the 
time of processing. Approximately 30 ml of urine 
were transferred to a tube and centrifuged at 2000 
rpm for five minutes. After centrifugation, the 
supernatant was discarded and the sediment resus-
pended in 5 ml of 50% ethanol and washed with 
HDF (solution of ultra-pure water containing 137 
mM NaCl, 5 mM KCl, 5.5 mM glucose, 4 mM 
NaHCO3, and 0.2% EDTA). Then, the material 
was submitted to cytocentrifugation on microscope 
slides with adhesive filter paper.
The prepared slides were fixed in 2% 
formaldehyde and 4% sucrose PBS at room 
temperature for 10 minutes. The slides were then 
washed in PBS for 5 minutes and treated with 0.3% 
Triton X-100 (Sigma-Aldrich, St. Louis, MO) for 10 
minutes to increase the permeability of the material. 
Another washing cycle with PBS was performed 
for 5 minutes, and then the material was sent for 
incubation for one hour with blocking buffer solu-
tion (PBS with 0.2% BSA, 50 mM NH4Cl, and 1% 
goat serum). After another washing cycle, the slides 
were incubated for 16 hours at 4°C with primary 
podocyte-specific antibodies: rabbit anti-podocin 
antibody (Sigma-Aldrich, St. Louis, MO), rabbit 
anti-nephrin antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA), and rabbit anti-synaptopodin 
antibody (Santa Cruz Biotechnology, Santa Cruz, 
CA). After washing, the slides were incubated with 
secondary antibody fluorescein-conjugated goat 
anti-rabbit IgG (FITC, Sigma-Aldrich, St. Louis, 
MO) for 45 minutes at room temperature. DAPI 
was used to stain nucleic acid. The slides were 
examined and photographed under 400x magni-
fication using a DM1000 epifluorescence micro-
scope (Leica Microsystems CMS GmbH, Wetzlar, 
Germany); positive and negative reaction controls 
were used in each procedure. The number of podo-
cytes in 30 randomly chosen fields of the slides were 
counted and the results were corrected based on 
the levels of urine creatinine found in each sample.
lab wOrkuP
Creatinine and proteinuria levels were measured using 
a commercial kit and an Olympus AU 400 Analyzer 
(Olympus Mishima Co. Ltd., Shizuoka, Japan).
Hematuria and leukocyturia in urinary 
sediments were assessed based on the mean number 
of red and white blood cells in 10 fields.
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Measurements of serum creatinine, 24-hour 
proteinuria, hematuria, and leukocyturia were 
made only for subjects in groups B, C, and D. 
Controls were not tested for these parameters.
statistical analysis
The following inferential statistics analyses were 
used: Spearman’s rank correlation coefficient, the 
Kruskal-Wallis test, and the Mann-Whitney U test. A 
level of significance of 5% was established for all tests.
results
The specificity of primary antibodies (rabbit 
anti-podocin antibody, rabbit anti-nephrin 
antibody, and rabbit anti-synaptopodin antibody) 
was confirmed by indirect immunofluorescence, 
using histological sections of normal human kidney 
tissue. When tested on slides with podocytes, the 
best results were obtained with the anti-podocin 
antibody, as it produced higher reactivity and lower 
nonspecific staining (Figure 1).
Podocyturia measurements by rabbit anti-podocin, 
anti-nephrin, and anti-synaptopodin antibodies are 
shown in Table 1.
Lab test results are shown in Table 2. In the 
control group, only protein/creatinine ratios and 
podocyturia were measured (Table 2), since these 
subjects were included in the study for having 
negative results in the urine test strip.
The diagnosis of podocyturia based on the 
anti-podocin antibody was correlated with 
active disease according to clinical and workup 
parameters, contrary to what was observed with 
the other two antibodies, anti-nephrin, and 
anti-synaptopodin, whose results did not correlate 
with disease severity.
Inferential results revealed that scores of 
podocyturia with anti-podocin (p < 0.001) and 
anti-nephrin (p = 0.047) antibodies were different in 
groups A, B, C, and D. The same was not observed 
for levels of podocyturia with the anti-synaptopodin 
(p = 0.107) antibody.
Protein/creatinine ratios (p < 0.001) and 24-hour 
proteinuria levels (p < 0.001) were not similar 
between groups. The results of multiple comparisons 
between groups are shown in Figures 2 and 3.
Figure 1. Podocyturia testing through indirect immunofluorescence 
staining. A: Positive leveling for anti-podocin antibody; B: Anti-nephrin 
antibody; C: Anti-synaptopodin antibody; superimposition of 
images related to staining with DAPI (blue) and specific antibodies 
(green). The colors described refer to the original image stained by 
immunofluorescence. 400x magnification.
The possible correlations between variables 
were assessed using Spearman’s rank correlation 
coefficient. Diagnoses of podocyturia with the 
anti-podocin and anti-synaptopodin antibodies 
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tAble 1 summary Of levels Of POdOcyturia based On anti-POdOcin, anti-nePhrin, and anti-synaPtOPOdin   
 (POdOcytes/mg Of creatinine) Of individuals in grOuPsa, b, c, and d
Antibody Group A Group B Group C Group D Total
Podocin N 29 17 29 10 85
25th percentile 0.00 9.23 5.73 47.71 2.99
50th percentile 3.78 17.47 22.59 109.13 16.28
75th percentile 17.11 50.37 55.74 173.63 49.60
Nephrin N 29 17 27 8 81
25th percentile 0.00 0.00 0.00 0.00 0.00
50th percentile 0.00 9.22 0.00 0.00 0.00
75th percentile 2.98 17.47 8.02 9.63 8.96
Synaptopodin N 29 17 28 9 83
25th percentile 0.00 0.00 0.00 0.00 0.00
50th percentile 0.00 0.00 0.00 2.82 0.00
75th percentile 0.00 4.31 3.80 6.57 2.99
tAble 2 summary Of levels Of 24-hOur PrOteinuria, serum creatinine, hematuria, leukOcyturia, PrOtein/  
 creatinine ratiO, POdOcyturia by anti-POdOcin, anti-nePhrin, and anti-synaPtOPOdin Of individuals in  
 grOuPs a, b, c, and d
Group A Group B Group C Group D Total
24-hour proteinuria (g/24h) N - 16 26 9 51
25th percentile - < 0.05 0.58 3.09 0.25
50th percentile - < 0.05 1.12 4.30 0.91
75th percentile - 0.26 1.89 5.73 2.56
Protein/creatinine ratio N 29 17 29 10 85
25th percentile < 0.05 < 0.05 0.55 2.66 < 0.05
50th percentile < 0.05 < 0.05 1.03 3.78 0.17
75th percentile < 0.05 0.33 1.80 7.07 1.21
Serum creatinine (mg/dL) N - 17 29 10 56
25th percentile - 0.65 0.80 0.73 0.71
50th percentile - 0.71 1.07 0.95 0.93
75th percentile - 0.99 2.19 1.39 1.36
Hematuria (phpf)a N - 17 29 10 56
25th percentile - 5.00 5.00 26.25 5.00
50th percentile - 8.00 10.00 32.50 12.50
75th percentile - 20.00 35.00 100.00 35.00
Leukocyturia (phpf)a N - 17 29 10 56
25th percentile - 5.00 7.00 14.00 5.00
50th percentile - 5.00 12.00 20.00 11.00
75th percentile - 12.00 15.00 68.75 20.00
a Results expressed in cells per high-power field (phpf).
were positively and statistically correlated with 
the protein/creatinine ratio (rs = 0.367, p = 0.001; 
and rs = 0.272, p = 0.013, respectively); diagnoses 
using the anti-nephrin and anti-synaptopodin 
antibodies were correlated with each other 
(rs = 0.317, p = 0.001); diagnosis of podocyturia 
using the anti-nephrin antibody was negatively and 
statistically correlated with 24-hour proteinuria 
(rs = -0.334, p = 0.022). The other possible 
correlations were not statistically significant.
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Figure 2. Levels of podocyturia (podocytes/mg of creatinine) of 
individuals in groups A, B, C, and D. A: Anti-podocin; B: Anti-nephrin.
Figure 3. Levels of proteinuria. A: Urine protein/creatinine ratios of 
individuals in groups A, B, C, and D; B: 24-hour proteinuria levels 
(g/24h) of individuals in groups B, C, and D.
dIscussIon
Studies have described the presence of viable 
podocytes in the urine of patients with various 
glomerular diseases and proteinuria. Unlike 
proteinuria - present in active disease and in the 
chronic stages of glomerular injury - podocyturia 
seems to be present only in cases of active disease.6,10 
Podocyturia is not an indicator for proteinuria,10 
and could thus serve as a sensitive early marker of 
active glomerular injury and an indicator of great 
value in the definition of therapy.1 Indeed, the levels 
of podocyturia in healthy individuals and patients 
with inactive disease has been shown to be signifi-
cantly lower than the levels seen in patients with 
active glomerular disease.11
In our study, the levels of leukocyturia, 
hematuria, serum creatinine, protein/creatinine 
ratio, and 24-hour proteinuria grew according to 
the degree of clinical activity, as also described by 
Solorzano et al.9 It was evident that the counts 
of podocin-positive and synaptopodin-positive 
cells in urine were significantly correlated with 
protein/creatinine ratios. In fact, a previous 
study carried out at our center9 found the 
protein/creatinine ratios of isolated urine samples 
were a good indicator of renal activity. This 
finding is of great importance, since this is a fast, 
easy-to-perform, low cost and well-established test 
in clinical practice. Solorzano et al.12 observed that 
the protein/creatinine ratio can also be used to 
monitor the degree of renal involvement in LN, as 
also found in our study.
The correlation of podocyturia with disease 
activity in patients with lupus nephritis suggested 
the anti-podocin antibody was the most suitable 
biomarker when compared with anti-nephrin 
and anti-synaptopodin. Garovic et al.13 reported 
similar results in the assessment of a group of 
pregnant women with preeclampsia. The authors 
analyzed the renal tissue of this group of patients 
and found reduced glomerular expression of 
nephrin and synaptopodin, while both the 
control group and the group with preeclampsia 
had strong labeling for podocin. According to 
these authors, the podocytes excreted in urine 
could have lower expression of nephrin and 
synaptopodin than podocin, thus making the 
latter a more sensitive marker for the presence of 
podocytes in urine.14
A similar finding was observed in a study 
on diabetic nephropathy, wherein the counts of 
podocyte-related molecules was correlated with 
severity of albuminuria.15
Gene expression of podocyte proteins (nephrin, 
podocin, synaptopodin, podocalyxin, among 
others) in renal tissue is reduced in different 
glomerulopathies including lupus nephritis. 
Increased urinary excretion of these markers has 
been observed due to detachment of podocytes 
from the glomerular basement membrane 
and/or apoptosis.16 Experimental studies have 
also described correlations between expression 
of nephrin and podocin and histological grade of 
lupus nephritis.17
Nakamura et al.6 reported podocyturia in a 
group of LN patients through immunofluorescence 
with the anti-podocalyxin antibody. Podocytes 
were not found in the urine of normal control 
subjects and patients without signs of systemic or 
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renal disease. However, all patients with clinically 
active LN had podocytes in their urine samples. 
The authors concluded that podocyturia diagnosed 
with the anti-podocalyxin antibody could serve as 
an indicator of active LN.
Vogelmann et al.3 studied patients with 
focal segmental glomerulosclerosis and LN and 
found that less than 1% of the nucleated cells 
from urine sediments stained with DAPI were 
podocalyxin-positive and that labeling for 
anti-WT1 was negative in all cases. Approximately 
30% to 40% of the podocalyxin-positive sam-
ples were labeled with synaptopodin, GLEPP1, 
or podocin. These reports and our study elicit 
the difficulties inherent to defining the most 
adequate markers for podocyturia using 
immunofluorescence staining.
Podocyturia labeled by the anti-podocin 
antibody was increased in patients with active LN. 
Podocin-positive cells were significantly correlated 
with disease severity, and cell counts were higher 
in patients with severe disease when compared to 
subjects with mild disease.
Patients without active disease had levels of 
podocyturia similar to the group with mild disease, 
and higher levels of podocyturia than controls, 
indicating that podocyturia may occur secondarily 
to early glomerular injury.
Podocytes were also seen in the urine of 
healthy individuals in the control group in all 
three markers used, but counts were lower than 
in patients with LN. Facca et al.18 studied women 
with preeclampsia and found podocytes in the 
urine of pregnant women without preeclampsia in 
the control group.
To sum up with, this study showed that 
podocyturia testing by indirect immunofluorescence 
may be useful in monitoring patients with LN. 
The anti-podocin antibody was the most suitable 
biomarker when compared to the anti-nephrin 
and anti-synaptopodin antibodies. The preliminary 
nature of our findings calls for more comprehensive 
investigations and clearer definitions for the 
clinical significance of podocyturia in various 
glomerulopathies. Methods with higher sensitivity 
to detect podocyturia are still needed.
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